Barcelona – July 2016. Tractivus is pleased to announce that Centro para el Desarrollo Tecnológico Industrial (CDTI) and the Structural Funds of the European Union has granted funding to Tractivus SL for the development of new personalized stents with bioactive properties during 2016-2017. Additionally, it also has the support of the Spanish Ministry of Economy, Industry and Competitiveness (MINECO).

​

During the next two years, Tractivus will design and validate the scalability process of the antibacterial stent and manufacturing process, start the in vivo experiments and defines the regulatory strategy for the preclinical experiments.